The Glucagon Receptor Is Required for the Adaptive Metabolic Response to Fasting

Peroxisome proliferator–activated receptor α mediates the adaptive response to fasting

Kersten, S., Seydoux, J., Peters, J. M., Gonzalez, F. J., Desvergne, B., & Wahli, W. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6223 · Cited by 1,649 · see citing works

Endocrine Regulation of the Fasting Response by PPARα-Mediated Induction of Fibroblast Growth Factor 21

Inagaki, T., Dutchak, P., Zhao, G., Ding, X., Gautron, L., Parameswara, V., Li, Y., Goetz, R., Mohammadi, M., Esser, V., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.05.003 · Cited by 1,504 · see citing works

Hepatic Fibroblast Growth Factor 21 Is Regulated by PPARα and Is a Key Mediator of Hepatic Lipid Metabolism in Ketotic States

Badman, M. K., Pissios, P., Kennedy, A. R., Koukos, G., Flier, J. S., & Maratos-Flier, E. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.05.002 · Cited by 1,495 · see citing works

The CREB coactivator TORC2 is a key regulator of fasting glucose metabolism

Koo, S., Flechner, L., Qi, L., Zhang, X., Screaton, R. A., Jeffries, S., Hedrick, S. A., Xu, W., Boussouar, F., Brindle, P. K., et al. (2005) · Nature · doi:10.1038/nature03967 · Cited by 993 · see citing works

Sorting out the roles of PPAR  in energy metabolism and vascular homeostasis

Lefebvre, P. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27989 · Cited by 962 · see citing works

Glucagon and regulation of glucose metabolism

Jiang, G., & Zhang, B. B. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00492.2002 · Cited by 905 · see citing works

Lower blood glucose, hyperglucagonemia, and pancreatic α cell hyperplasia in glucagon receptor knockout mice

Gelling, R. W., Du, X. Q., Dichmann, D. S., Rømer, J., Huang, H., Cui, L., Obici, S., Tang, B., Holst, J. J., Fledelius, C., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0237106100 · Cited by 563 · see citing works

ADD1/SREBP-1c Is Required in the Activation of Hepatic Lipogenic Gene Expression by Glucose

Foretz, M., Pacot, C., Dugail, I., Lemarchand, P., Guichard, C., Lièpvre, X. L., Lubrano-Berthelier, C., Spiegelman, B. M., Kim, J. B., Ferré, P., et al. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.5.3760 · Cited by 548 · see citing works

International Union of Pharmacology. XXXV. The Glucagon Receptor Family

Mayo, K. E., Miller, L. J., BATAILLE, D., Dalle, S., Göke, B., Thorens, B., & Drucker, D. J. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.1.6 · Cited by 507 · see citing works

Expression cloning and signaling properties of the rat glucagon receptor

Jelinek, L., Lok, S., Rosenberg, G., Smith, R., Grant, F., BIGGS, S., Bensch, P., Kuijper, J. L., Sheppard, P. O., Sprecher, C. A., et al. (1993) · Science · doi:10.1126/science.8384375 · Cited by 397 · see citing works

Activation of two signal-transduction systems in hepatocytes by glucagon

Wakelam, M. J. O., Murphy, G. J., Hruby, V. J., & Houslay, M. D. (1986) · Nature · doi:10.1038/323068a0 · Cited by 389 · see citing works

Peroxisome Proliferator-Activated Receptor α Mediates the Effects of High-Fat Diet on Hepatic Gene Expression

Patsouris, D., Reddy, J. K., Müller, M. M., & Kersten, S. (2005) · Endocrinology · doi:10.1210/en.2005-1132 · Cited by 339 · see citing works

CREB controls hepatic lipid metabolism through nuclear hormone receptor PPAR-γ

Herzig, S., Hedrick, S. A., Morantte, I. G., Koo, S., Galimi, F., & Montminy, M. (2003) · Nature · doi:10.1038/nature02110 · Cited by 321 · see citing works

The use of a non‐ionic detergent (Triton WR 1339) to determine rates of triglyceride entry into the circulation of the rat under different physiological conditions

Otway, S., & Robinson, D. S. (1967) · The Journal of Physiology · doi:10.1113/jphysiol.1967.sp008211 · Cited by 288 · see citing works

Glucagon physiology and pathophysiology

Sherwood, L. M., Parris, E. E., & Unger, R. H. (1971) · New England Journal of Medicine · doi:10.1056/nejm197108192850806 · Cited by 267 · see citing works

Glucagon receptor knockout mice are resistant to diet-induced obesity and streptozotocin-mediated beta cell loss and hyperglycaemia

Conarello, S. L., Jiang, G., Mu, J., Li, Z., Woods, J., Zycband, E., Ronan, J., Liu, F., Roy, R. S., Zhu, L., et al. (2006) · Diabetologia · doi:10.1007/s00125-006-0481-3 · Cited by 224 · see citing works

Hepatic and glucagon-like peptide-1–mediated reversal of diabetes by glucagon receptor antisense oligonucleotide inhibitors

Sloop, K. W., Cao, J. X. C., Siesky, A. M., Zhang, H. Y., Bodenmiller, D. M., Cox, A. L., Jacobs, S. J., Moyers, J. S., Owens, R. A., Showalter, A. D., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci20911 · Cited by 219 · see citing works

Reduction in Glucagon Receptor Expression by an Antisense Oligonucleotide Ameliorates Diabetic Syndrome in db/db Mice

Liang, Y. T., Osborne, M. C., Monia, B. P., Bhanot, S., Gaarde, W. A., Reed, C. A., She, P., Jetton, T. L., & Demarest, K. T. (2004) · Diabetes · doi:10.2337/diabetes.53.2.410 · Cited by 203 · see citing works

Hyperglucagonemia and Its Suppression

Raskin, P., & Unger, R. H. (1978) · New England Journal of Medicine · doi:10.1056/nejm197808312990901 · Cited by 197 · see citing works

Hyperglycemia of Diabetic Rats Decreased by a Glucagon Receptor Antagonist

Johnson, D. G., Goebel, C. U., Hruby, V. J., Bregman, M. D., & Trivedi, D. B. (1982) · Science · doi:10.1126/science.6278587 · Cited by 166 · see citing works

Incretin Receptors for Glucagon-Like Peptide 1 and Glucose-Dependent Insulinotropic Polypeptide Are Essential for the Sustained Metabolic Actions of Vildagliptin in Mice

Flock, G. B., Baggio, L. L., Longuet, C., & Drucker, D. J. (2007) · Diabetes · doi:10.2337/db07-0697 · Cited by 164 · see citing works

p38 Mitogen-activated Protein Kinase Plays a Stimulatory Role in Hepatic Gluconeogenesis

Cao, W., Collins, Q. F., Becker, T. C., Robidoux, J., Lupo, E. G., Xiong, Y., Daniel, K. W., Floering, L. M., & Collins, S. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m506223200 · Cited by 146 · see citing works

Glucagon Represses Signaling through the Mammalian Target of Rapamycin in Rat Liver by Activating AMP-activated Protein Kinase

Kimball, S. R., Siegfried, B. A., & Jefferson, L. S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m410755200 · Cited by 133 · see citing works

Factors affecting lipoprotein metabolism.

Scanu, A. M. (1965) · PubMed · Cited by 133 · see citing works

Biological activities of des-His1[Glu9]glucagon amide, a glucagon antagonist

Unson, C. G., Gurzenda, E. M., & Merrifield, R. B. (1989) · Peptides · doi:10.1016/0196-9781(89)90010-7 · Cited by 119 · see citing works

Evidence That Peroxisome Proliferator-activated Receptor α Is Complexed with the 90-kDa Heat Shock Protein and the Hepatitis Virus B X-associated Protein 2

Sumanasekera, W. K., Tien, E. S., Turpey, R., Heuvel, J. P. V., & Perdew, G. H. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211261200 · Cited by 108 · see citing works

Effects of ethanol on mitogen-activated protein kinase and stress-activated protein kinase cascades in normal and regenerating liver

Jianping, C. H. E. N., Ishac, E. J. N., Dent, P., Kunos, G., & Gao, B. (1998) · Biochemical Journal · doi:10.1042/bj3340669 · Cited by 107 · see citing works

Factors Affecting Lipoprotein Metabolism1 1This work was supported by grants from the Public Health Service (HE 08727-01) and from the Chicago and Illinois Heart Associations.2 2Literature published after June 30, 1964, is not included in this survey.

Scanu, A. M. (1965) · Advances in lipid research · doi:10.1016/b978-1-4831-9939-9.50009-7 · Cited by 99 · see citing works

p38 Mitogen-activated Protein Kinase Plays an Inhibitory Role in Hepatic Lipogenesis

Xiong, Y., Collins, Q. F., An, J., Lupo, E. G., Liu, H. Y., Liu, D., Robidoux, J., Liu, Z., & Cao, W. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m606742200 · Cited by 93 · see citing works

Hypolipemic action of glucagon in experimental endogenous lipemia in the rat

Eaton, R. P. (1973) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)36889-9 · Cited by 86 · see citing works

Characterization of protein-DNA interactions within the peroxisome proliferator-responsive element of the rat hydratase-dehydrogenase gene

Zhang, B., Marcus, S. L., Miyata, K., Subramani, S. E., Capone, J. P., & Rachubinski, R. A. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)31476-5 · Cited by 79 · see citing works

Heat Shock Protein-90 (Hsp90) Acts as a Repressor of Peroxisome Proliferator-Activated Receptor-α (PPARα) and PPARβ Activity

Sumanasekera, W. K., Tien, E. S., Davis, J. W., Turpey, R., Perdew, G. H., & Heuvel, J. P. V. (2003) · Biochemistry · doi:10.1021/bi0347353 · Cited by 78 · see citing works

Evidence that the sensitivity of carnitine palmitoyltransferase I to inhibition by malonyl-CoA is an important site of regulation of hepatic fatty acid oxidation in the fetal and newborn rabbit. Perinatal development and effects of pancreatic hormones in cultured rabbit hepatocytes

Prip‐Buus, C., Pégorier, J. P., Duée, P., Kohl, C., & Girard, J. R. (1990) · Biochemical Journal · doi:10.1042/bj2690409 · Cited by 73 · see citing works

tBid induces alterations of mitochondrial fatty acid oxidation flux by malonyl-CoA-independent inhibition of carnitine palmitoyltransferase-1

Giordano, A., Calvani, M., Petillo, O., Grippo, P., Tuccillo, F. M., Melone, M. A. B., Bonelli, P., Calarco, A., & Peluso, G. (2005) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401636 · Cited by 65 · see citing works

Glucagon activates Ca2+ and Cl− channels in rat hepatocytes

Aromataris, E., Roberts, M. L., Barritt, G. J., & Rychkov, G. Y. (2006) · The Journal of Physiology · doi:10.1113/jphysiol.2006.109819 · Cited by 62 · see citing works

Activation of Glucagon-Like Peptide-1 Receptor Signaling Does Not Modify the Growth or Apoptosis of Human Pancreatic Cancer Cells

Koehler, J. A., & Drucker, D. J. (2006) · Diabetes · doi:10.2337/db05-1145 · Cited by 60 · see citing works

Prevention of Fatty Liver in Transition Dairy Cows by Subcutaneous Injections of Glucagon

Nafikov, R. A., Ametaj, B. N., Bobe, G., Koehler, K. J., Young, J. W., & Beitz, D. C. (2006) · Journal of Dairy Science · doi:10.3168/jds.s0022-0302(06)72221-4 · Cited by 50 · see citing works

Squalene synthase inhibitors suppress triglyceride biosynthesis through the farnesol pathway in rat hepatocytes

Hiyoshi, H., Yanagimachi, M., Ito, M., Yasuda, N., Okada, T., Ikuta, H., Shinmyo, D., Tanaka, K., Kurusu, N., Yoshida, I., et al. (2003) · Journal of Lipid Research · doi:10.1194/jlr.m200316-jlr200 · Cited by 47 · see citing works

Effects of Exogenous Glucagon on Lipids in Lipoproteins and Liver of Lactating Dairy Cows

Bobe, G., Ametaj, B. N., Young, J. W., & Beitz, D. C. (2003) · Journal of Dairy Science · doi:10.3168/jds.s0022-0302(03)73886-7 · Cited by 42 · see citing works

Evidence of Hepatic Glucagon Resistance Associated with Hepatic Steatosis: Reversal Effect of Training

Charbonneau, A., Couturier, K., Gauthier, M., & Lavoie, J.-M. (2005) · International Journal of Sports Medicine · doi:10.1055/s-2004-821225 · Cited by 40 · see citing works

Effects of chronic glucagon administration on cholesterol and bile acid metabolism

Guettet, C., Mathé, D., Riottot, M., & Lutton, C. (1988) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(88)90283-4 · Cited by 36 · see citing works

Potential Treatment of Fatty Liver with 14-Day Subcutaneous Injections of Glucagon

Bobe, G., Ametaj, B. N., Young, J. W., & Beitz, D. C. (2003) · Journal of Dairy Science · doi:10.3168/jds.s0022-0302(03)73915-0 · Cited by 36 · see citing works

Effects of chronic glucagon administration on rat lipoprotein composition

Guettet, C., Mathé, D., Navarro, N., & Lecuyer, B. (1989) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(89)90042-8 · Cited by 33 · see citing works

Effect of chronic glucagon administration on lipoprotein composition in normally fed, fasted and cholesterol‐fed rats

Guettet, C., Rostaqui, N., Mathé, D., Lécuyer, B., Navarro, N., & JACOTOT, B. (1991) · Lipids · doi:10.1007/bf02536072 · Cited by 29 · see citing works

Alterations in hepatic glucagon receptor density and in Gsα and Giα2protein content with diet-induced hepatic steatosis: effects of acute exercise

Charbonneau, A., Melançon, A., Lavoie, C., & Lavoie, J.-M. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00570.2004 · Cited by 27 · see citing works

Differences in the Formation of PPARα-RXR/acoPPRE Complexes between Responsive and Nonresponsive Species upon Fibrate Administration

Rodrı́guez, C., Noé, V., Cabrero, À., Ciudad, C. J., & Laguna, J. C. (2000) · Molecular Pharmacology · doi:10.1124/mol.58.1.185 · Cited by 22 · see citing works

Exogenous glucagon effects on health and reproductive performance of lactating dairy cows with mild fatty liver

Bobe, G., Ametaj, B. N., Young, J. W., Anderson, L. L., & Beitz, D. C. (2006) · Animal Reproduction Science · doi:10.1016/j.anireprosci.2006.11.003 · Cited by 10 · see citing works

Energy Metabolism in the Liver

Rui, L. (2014) · Comprehensive physiology · doi:10.1002/cphy.c130024 · Cited by 2,258 · see citing works

Regulation of hepatic glucose metabolism in health and disease

Petersen, M. C., Vatner, D. F., & Shulman, G. I. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2017.80 · Cited by 1,131 · see citing works

Metabolism disrupting chemicals and metabolic disorders

Heindel, J. J., Blumberg, B., Cave, M., Machtinger, R., Mantovani, A., Mendez, M. A., Nadal, A., Palanza, P., Panzica, G., Sargis, R., et al. (2017) · Reproductive Toxicology · doi:10.1016/j.reprotox.2016.10.001 · Cited by 1,101 · see citing works

Mechanisms of hepatic triglyceride accumulation in non-alcoholic fatty liver disease

Kawano, Y., & Cohen, D. E. (2013) · Journal of Gastroenterology · doi:10.1007/s00535-013-0758-5 · Cited by 968 · see citing works

FGF21 induces PGC-1α and regulates carbohydrate and fatty acid metabolism during the adaptive starvation response

Potthoff, M. J., Inagaki, T., Satapati, S., Ding, X., He, T., Goetz, R., Mohammadi, M., Finck, B. N., Mangelsdorf, D. J., Kliewer, S. A., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0904187106 · Cited by 704 · see citing works

Glucagonocentric restructuring of diabetes: A pathophysiologic and therapeutic makeover

Unger, R. H., & Cherrington, A. D. (2012) · Journal of Clinical Investigation · doi:10.1172/jci60016 · Cited by 670 · see citing works

GLP-1 physiology informs the pharmacotherapy of obesity

Drucker, D. J. (2022) · Molecular Metabolism · doi:10.1016/j.molmet.2021.101351 · Cited by 510 · see citing works

Physiology of Proglucagon Peptides: Role of Glucagon and GLP-1 in Health and Disease

Sandoval, D. A., & D'Alessio, D. A. (2015) · Physiological Reviews · doi:10.1152/physrev.00013.2014 · Cited by 498 · see citing works

The metabolic actions of glucagon revisited

Habegger, K. M., Heppner, K. M., Geary, N., Bartness, T. J., DiMarchi, R., & Tschöp, M. H. (2010) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2010.187 · Cited by 406 · see citing works

Glucagon-Like Peptide 1/Glucagon Receptor Dual Agonism Reverses Obesity in Mice

Pocai, A., Carrington, P. E., Adams, J. R., Wright, M., Eiermann, G., Zhu, L., Du, X., Petrov, A., Lassman, M. E., Jiang, G., et al. (2009) · Diabetes · doi:10.2337/db09-0278 · Cited by 409 · see citing works

Distinct but complementary contributions of PPAR isotypes to energy homeostasis

Dubois, V., Eeckhoute, J., Lefèbvre, P., & Staels, B. (2017) · Journal of Clinical Investigation · doi:10.1172/jci88894 · Cited by 385 · see citing works

Efficacy and Safety of GLP-1 Medicines for Type 2 Diabetes and Obesity

Drucker, D. J. (2024) · Diabetes Care · doi:10.2337/dci24-0003 · Cited by 383 · see citing works

Energy Metabolism in the Liver

Rui, L. (2014) · Comprehensive physiology · doi:10.1002/j.2040-4603.2014.tb00548.x · Cited by 382 · see citing works

Role of Mitochondria in Nonalcoholic Fatty Liver Disease

Nassir, F., & Ibdah, J. A. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15058713 · Cited by 359 · see citing works

Glucagon-like peptide-1 receptor co-agonists for treating metabolic disease.

Baggio, L. L., & Drucker, D. J. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2020.101090 · Cited by 299 · see citing works

The glucagon-like peptide 1 receptor is essential for postprandial lipoprotein synthesis and secretion in hamsters and mice

Hsieh, J., Longuet, C., Baker, C. L., Qin, B., Federico, L. M., Drucker, D. J., & Adeli, K. (2009) · Diabetologia · doi:10.1007/s00125-009-1611-5 · Cited by 276 · see citing works

Islet α cells and glucagon--critical regulators of energy homeostasis

Campbell, J. E., & Drucker, D. J. (2015) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2015.51 · Cited by 266 · see citing works

The role of dysregulated glucagon secretion in type 2 diabetes

D'Alessio, D. (2011) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2011.01449.x · Cited by 238 · see citing works

OCT1 is a high-capacity thiamine transporter that regulates hepatic steatosis and is a target of metformin

Chen, L., Shu, Y., Liang, X., Chen, E. C., Yee, S. W., Zur, A. A., Li, S., Xu, L., Keshari, K. R., Lin, M. J., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1314939111 · Cited by 234 · see citing works

Glucagon Receptor Signaling and Lipid Metabolism

Galsgaard, K. D., Pedersen, J., Knop, F. K., Holst, J. J., & Wewer Albrechtsen, N. J. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.00413 · Cited by 218 · see citing works

Structure of the full-length glucagon class B G-protein-coupled receptor

Zhang, H., Qiao, A., Yang, D., Yang, L., Dai, A., de Graaf, C., Reedtz‐Runge, S., Dharmarajan, V., Zhang, H., Han, G. W., et al. (2017) · Nature · doi:10.1038/nature22363 · Cited by 212 · see citing works

Interrupted Glucagon Signaling Reveals Hepatic α Cell Axis and Role for L-Glutamine in α Cell Proliferation

Dean, E. D., Li, M., Prasad, N., Wisniewski, S., Deylen, A. V., Spaeth, J. M., Maddison, L. A., Botros, A., Sedgeman, L. R., Bozadjieva-Kramer, N., et al. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.05.011 · Cited by 207 · see citing works

Alpha-, Delta- and PP-cells: Are They the Architectural Cornerstones of Islet Structure and Co-ordination?

Brereton, M. F., Vergari, E., Zhang, Q., & Clark, A. (2015) · Journal of Histochemistry & Cytochemistry · doi:10.1369/0022155415583535 · Cited by 206 · see citing works

Glucagon Receptor Signaling and Glucagon Resistance

Janah, L., Kjeldsen, S. A. S., Galsgaard, K. D., Winther‐Sørensen, M., Stojanovska, E., Pedersen, J., Knop, F. K., Holst, J. J., & Albrechtsen, N. J. W. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20133314 · Cited by 205 · see citing works

Glucagon and Amino Acids Are Linked in a Mutual Feedback Cycle: The Liver–α-Cell Axis

Holst, J. J., Wewer Albrechtsen, N. J., Pedersen, J., & Knop, F. K. (2017) · Diabetes · doi:10.2337/db16-0994 · Cited by 187 · see citing works

Glucagon-like Peptide-1 Receptor-based Therapeutics for Metabolic Liver Disease

Yabut, J. M., & Drucker, D. J. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnac018 · Cited by 180 · see citing works

Acetate Revisited: A Key Biomolecule at the Nexus of Metabolism, Epigenetics and Oncogenesis—Part 1: Acetyl-CoA, Acetogenesis and Acyl-CoA Short-Chain Synthetases

Moffett, J. R., Puthillathu, N., Vengilote, R., Jaworski, D. M., & Namboodiri, A. M. A. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.580167 · Cited by 182 · see citing works

Treatment with <scp>LY</scp> 2409021, a glucagon receptor antagonist, increases liver fat in patients with type 2 diabetes

Guzman, C. B., Zhang, X. M., Liu, R., Regev, A., Shankar, S., Garhyan, P., Pillai, S. G., Kazda, C., Chalasani, N., & Hardy, T. A. (2017) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12958 · Cited by 172 · see citing works

The Role of Glucagon in the Pathophysiology and Treatment of Type 2 Diabetes

Hædersdal, S., Lund, A., Knop, F. K., & Vilsbøll, T. (2018) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2017.12.003 · Cited by 162 · see citing works

Activation of the Farnesoid X Receptor Induces Hepatic Expression and Secretion of Fibroblast Growth Factor 21

Cyphert, H. A., Ge, X., Kohan, A. B., Salati, L. M., Zhang, Y., & Hillgartner, F. B. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.375907 · Cited by 162 · see citing works

Revisiting the role of glucagon in health, diabetes mellitus and other metabolic diseases

Hædersdal, S., Andersen, A., Knop, F. K., & Vilsbøll, T. (2023) · Nature Reviews Endocrinology · doi:10.1038/s41574-023-00817-4 · Cited by 164 · see citing works

The Liver–α-Cell Axis and Type 2 Diabetes

Albrechtsen, N. J. W., Pedersen, J., Galsgaard, K. D., Winther‐Sørensen, M., Suppli, M. P., Janah, L., Gromada, J., Vilstrup, H., Knop, F. K., & Holst, J. J. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00251 · Cited by 149 · see citing works

High protein intake reduces intrahepatocellular lipid deposition in humans

Bortolotti, M., Kreis, R., Debard, C., Cariou, B., Faeh, D., Chetiveaux, M., Ith, M., Vermathen, P., Stefanoni, N., Lê, K.-A., et al. (2009) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2008.27296 · Cited by 146 · see citing works

Targeting the glucagon receptor family for diabetes and obesity therapy

Cho, Y. M., Merchant, C. E., & Kieffer, T. J. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.05.009 · Cited by 142 · see citing works

Structure of the glucagon receptor in complex with a glucagon analogue

Zhang, H., Qiao, A., Yang, L., Eps, N. V., Frederiksen, K. S., Yang, D., Dai, A., Cai, X., Zhang, H., Yi, C., et al. (2018) · Nature · doi:10.1038/nature25153 · Cited by 141 · see citing works

Important Hormones Regulating Lipid Metabolism

Zhang, D., Wei, Y., Huang, Q., Chen, Y., Zeng, K., Yang, W., Chen, J., & Chen, J. (2022) · Molecules · doi:10.3390/molecules27207052 · Cited by 143 · see citing works

Dissociating fatty liver and diabetes

Sun, Z., & Lazar, M. A. (2012) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2012.09.005 · Cited by 136 · see citing works

Integrating the inputs that shape pancreatic islet hormone release

Noguchi, G. M., & Huising, M. O. (2019) · Nature Metabolism · doi:10.1038/s42255-019-0148-2 · Cited by 130 · see citing works

Influence of Dietary Macronutrients on Liver Fat Accumulation and Metabolism

Parry, S. A., & Hodson, L. (2017) · Journal of Investigative Medicine · doi:10.1136/jim-2017-000524 · Cited by 131 · see citing works

AKR-001, an Fc-FGF21 Analog, Showed Sustained Pharmacodynamic Effects on Insulin Sensitivity and Lipid Metabolism in Type 2 Diabetes Patients

Kaufman, A., Abuqayyas, L., Denney, W. S., Tillman, E. J., & Rolph, T. (2020) · Cell Reports Medicine · doi:10.1016/j.xcrm.2020.100057 · Cited by 131 · see citing works

Gut-liver interaction in triglyceride-rich lipoprotein metabolism

Xiao, C., Hsieh, J., Adeli, K., & Lewis, G. F. (2011) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00178.2011 · Cited by 126 · see citing works

Hepatic transcriptional responses to fasting and feeding

Bideyan, L., Nagari, R., & Tontonoz, P. (2021) · Genes &amp; Development · doi:10.1101/gad.348340.121 · Cited by 126 · see citing works

Update on the molecular biology of dyslipidemias

Ramasamy, I. (2015) · Clinica Chimica Acta · doi:10.1016/j.cca.2015.10.033 · Cited by 126 · see citing works

Benefits and limitations of reducing glucagon action for the treatment of type 2 diabetes

Ali, S., & Drucker, D. J. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90887.2008 · Cited by 124 · see citing works

Glucagon-to-insulin ratio is pivotal for splanchnic regulation of FGF-21 in humans

Hansen, J. S., Clemmesen, J. O., Secher, N. H., Hoene, M., Drescher, A., Weigert, C., Pedersen, B. K., & Plomgaard, P. (2015) · Molecular Metabolism · doi:10.1016/j.molmet.2015.06.001 · Cited by 123 · see citing works

Repositioning Glucagon Action in the Physiology and Pharmacology of Diabetes

Finan, B., Capozzi, M. E., & Campbell, J. E. (2019) · Diabetes · doi:10.2337/dbi19-0004 · Cited by 117 · see citing works

Metabolic Syndrome and Male Fertility

Martins, A. D., Majzoub, A. A., & Agawal, A. (2018) · The World Journal of Men s Health · doi:10.5534/wjmh.180055 · Cited by 115 · see citing works

Glucagon-Induced Acetylation of Foxa2 Regulates Hepatic Lipid Metabolism

von Meyenn, F., Porstmann, T., Gasser, E., Selevsek, N., Schmidt, A., Aebersold, R. H., & Stoffel, M. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.01.014 · Cited by 114 · see citing works

Short‐term administration of the glucagon receptor antagonist <scp>LY2409021</scp> lowers blood glucose in healthy people and in those with type 2 diabetes

Kelly, R. P., Garhyan, P., Raddad, E., Fu, H., Lim, C. N., Prince, M. J., Pinaire, J. A., Loh, M. T., & Deeg, M. A. (2015) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12446 · Cited by 110 · see citing works

Transcriptional and Chromatin Regulation during Fasting – The Genomic Era

Goldstein, I., & Hager, G. L. (2015) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2015.09.005 · Cited by 110 · see citing works

The past, present, and future physiology and pharmacology of glucagon

Capozzi, M. E., D’Alessio, D. A., & Campbell, J. E. (2022) · Cell Metabolism · doi:10.1016/j.cmet.2022.10.001 · Cited by 110 · see citing works

Recent insights into fatty liver, metabolic dyslipidaemia and their links to insulin resistance

Savage, D. B., & Semple, R. K. (2010) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e32833b7782 · Cited by 109 · see citing works

Hepatic energy state is regulated by glucagon receptor signaling in mice

Berglund, E. D., Lee, R. S., Lustig, D. G., Lynes, S. E., Donahue, E. P., Camacho, R. C., Meredith, M. E., Magnuson, M. A., Charron, M. J., & Wasserman, D. H. (2009) · Journal of Clinical Investigation · doi:10.1172/jci38650 · Cited by 106 · see citing works

Major Facilitator Superfamily Domain-Containing Protein 2a (MFSD2A) Has Roles in Body Growth, Motor Function, and Lipid Metabolism

Berger, J. H., Charron, M. J., & Silver, D. L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050629 · Cited by 105 · see citing works

Glucagon Receptor Blockade With a Human Antibody Normalizes Blood Glucose in Diabetic Mice and Monkeys

Okamoto, H., Kim, J., Aglione, J., Lee, J., Cavino, K., Na, E., Rafique, A., Kim, J. H., Harp, J., Valenzuela, D. M., et al. (2015) · Endocrinology · doi:10.1210/en.2015-1011 · Cited by 100 · see citing works

Emerging role of AMP-activated protein kinase in endocrine control of metabolism in the liver

Hasenour, C. M., Berglund, E. D., & Wasserman, D. H. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.06.018 · Cited by 98 · see citing works

Determinants of VLDL-triglycerides production

Nielsen, S., & Karpe, F. (2012) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e3283544956 · Cited by 94 · see citing works

Glucagon Receptor Signaling Regulates Energy Metabolism via Hepatic Farnesoid X Receptor and Fibroblast Growth Factor 21

Kim, T., Nason, S., Holleman, C., Pepin, M., Wilson, L., Berryhill, T. F., Wende, A. R., Steele, C., Young, M. E., Barnes, S., et al. (2018) · Diabetes · doi:10.2337/db17-1502 · Cited by 97 · see citing works

Mechanisms of hepatic fatty acid oxidation and ketogenesis during fasting

Ruppert, P. M. M., & Kersten, S. (2023) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2023.10.002 · Cited by 97 · see citing works

Gut hormone-based pharmacology: novel formulations and future possibilities for metabolic disease therapy

Tschöp, M., Nogueiras, R., & Ahrén, B. (2023) · Diabetologia · doi:10.1007/s00125-023-05929-0 · Cited by 92 · see citing works

Glucagon increases circulating fibroblast growth factor 21 independently of endogenous insulin levels: a novel mechanism of glucagon-stimulated lipolysis?

Arafat, A. M., Kaczmarek, P., Skrzypski, M., Pruszyńska‐Oszmałek, E., Kolodziejski, P. A., Szczepankiewicz, D., Sassek, M., Wojciechowicz, T., Wiedenmann, B. J., Pfeiffer, A. F. H., et al. (2012) · Diabetologia · doi:10.1007/s00125-012-2803-y · Cited by 90 · see citing works

Glucagon Control on Food Intake and Energy Balance

Al–Massadi, O., Fernø, J., Diéguez, C., Nogueiras, R., & Quiñones, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20163905 · Cited by 89 · see citing works

Investigational glucagon receptor antagonists in Phase I and II clinical trials for diabetes

Scheen, A. J., Paquot, N., & Lefèbvre, P. J. (2017) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2017.1395020 · Cited by 87 · see citing works

The Liver–α-Cell Axis in Health and in Disease

Richter, M. M., Galsgaard, K. D., Elmelund, E., Knop, F. K., Suppli, M. P., Holst, J. J., Winther‐Sørensen, M., Kjeldsen, S. A. S., & Albrechtsen, N. J. W. (2022) · Diabetes · doi:10.2337/dbi22-0004 · Cited by 87 · see citing works

Polyomic profiling reveals significant hepatic metabolic alterations in glucagon-receptor (GCGR) knockout mice: implications on anti-glucagon therapies for diabetes

Yang, J., MacDougall, M. L., McDowell, M. T., Xi, L., Wei, R., Zavadoski, W. J., Molloy, M. P., Baker, J. D., Kühn, M., Cabrera, O., et al. (2011) · BMC Genomics · doi:10.1186/1471-2164-12-281 · Cited by 82 · see citing works

Glucagon Stimulates Hepatic FGF21 Secretion through a PKA- and EPAC-Dependent Posttranscriptional Mechanism

Cyphert, H. A., Alonge, K. M., Ippagunta, S. M., & Hillgartner, F. B. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094996 · Cited by 80 · see citing works

Glucagon Receptor Antagonism Improves Glucose Metabolism and Cardiac Function by Promoting AMP-Mediated Protein Kinase in Diabetic Mice

Sharma, A. X., Quittner-Strom, E. B., Lee, Y., Johnson, J. A., Martin, S. A., Yu, X., Li, J., Lu, J., Cai, Z. P., Chen, S., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.01.065 · Cited by 72 · see citing works

Insights into the Hexose Liver Metabolism—Glucose versus Fructose

Geidl-Flueck, B., & Gerber, P. (2017) · Nutrients · doi:10.3390/nu9091026 · Cited by 85 · see citing works

5-Aminoimidazole-4-carboxamide-1-β-d-ribofuranoside (AICAR) Effect on Glucose Production, but Not Energy Metabolism, Is Independent of Hepatic AMPK in Vivo

Hasenour, C. M., Ridley, D. E., Hughey, C. C., James, F. D., Donahue, E. P., Shearer, J., Viollet, B., Foretz, M., & Wasserman, D. H. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.528232 · Cited by 69 · see citing works

Cardiomyocyte glucagon receptor signaling modulates outcomes in mice with experimental myocardial infarction

Ali, S., Ussher, J. R., Baggio, L. L., Kabir, M. G., Charron, M. J., Ilkayeva, O., Newgard, C. B., & Drucker, D. J. (2014) · Molecular Metabolism · doi:10.1016/j.molmet.2014.11.005 · Cited by 69 · see citing works

Remodeling of Hepatic Metabolism and Hyperaminoacidemia in Mice Deficient in Proglucagon-Derived Peptides

Watanabe, C., Seino, Y., Miyahira, H., Yamamoto, M., Fukami, A., Ozaki, N., Takagishi, Y., Sato, J., Fukuwatari, T., Shibata, K., et al. (2011) · Diabetes · doi:10.2337/db11-0739 · Cited by 70 · see citing works

Lack of glucagon receptor signaling and its implications beyond glucose homeostasis

Charron, M. J., & Vuguin, P. M. (2015) · Journal of Endocrinology · doi:10.1530/joe-14-0614 · Cited by 68 · see citing works

Characterization of major elements of insulin signaling cascade in chicken adipose tissue: Apparent insulin refractoriness

Dupont, J., Métayer, S., Ji, B., Ramé, C., Gespach, C. P., Voy, B. H., & Simon, J. (2012) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2011.12.030 · Cited by 61 · see citing works

Hepatic Glucagon Signaling Regulates PCSK9 and Low-Density Lipoprotein Cholesterol

Spolitu, S., Okamoto, H., Dai, W., Zadroga, J. A., Wittchen, E. S., Gromada, J., & Özcan, L. (2019) · Circulation Research · doi:10.1161/circresaha.118.313648 · Cited by 61 · see citing works

Futile lipid cycling: from biochemistry to physiology

Sharma, A. K., Khandelwal, R., & Wolfrum, C. (2024) · Nature Metabolism · doi:10.1038/s42255-024-01003-0 · Cited by 60 · see citing works

Effects of Acute Hyperglucagonemia on Hepatic and Intestinal Lipoprotein Production and Clearance in Healthy Humans

Xiao, C., Pavlic, M., Szeto, L., Patterson, B. W., & Lewis, G. F. (2010) · Diabetes · doi:10.2337/db10-0763 · Cited by 60 · see citing works

Glucagon's Metabolic Action in Health and Disease

Zeigerer, A., Sekar, R., Kleinert, M., Nason, S. R., Habegger, K. M., & Müller, T. D. (2021) · Comprehensive physiology · doi:10.1002/cphy.c200013 · Cited by 76 · see citing works

Hypoxia via ERK Signaling Inhibits Hepatic PPARα to Promote Fatty Liver

Mooli, R. G. R., Rodriguez, J., Takahashi, S., Solanki, S. A., Gonzalez, F. J., Ramakrishnan, S. K., & Shah, Y. M. (2021) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2021.03.011 · Cited by 59 · see citing works

Hepatic glucagon action: beyond glucose mobilization

Kajani, S., Laker, R. C., Ratkova, E. L., Will, S., & Rhodes, C. J. (2024) · Physiological Reviews · doi:10.1152/physrev.00028.2023 · Cited by 60 · see citing works

Regulator of G Protein Signaling (RGS16) Inhibits Hepatic Fatty Acid Oxidation in a Carbohydrate Response Element-binding Protein (ChREBP)-dependent Manner

Pashkov, V., Huang, J., Parameswara, V., Kędzierski, W., Kurrasch, D. M., Tall, G. G., Esser, V., Gerard, R. D., Uyeda, K., Towle, H. C., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.216234 · Cited by 59 · see citing works

Glucagon in artificial pancreas systems: Potential benefits and safety profile of future chronic use

Taleb, N., Haidar, A., Messier, V., Gingras, V., Legault, L., & RABASA-LHORET, R. P. R. (2016) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12789 · Cited by 59 · see citing works

Hyperglucagonemia in youth is associated with high plasma free fatty acids, visceral adiposity, and impaired glucose tolerance

Manell, H., Kristinsson, H., Kullberg, J., Ubhayasekera, S. J. K. A., Mörwald, K., Staaf, J., Cadamuro, J., Zsoldos, F., Göpel, S., Sargsyan, E., et al. (2019) · Pediatric Diabetes · doi:10.1111/pedi.12890 · Cited by 56 · see citing works

Reprogramming of Hepatic Metabolism and Microenvironment in Nonalcoholic Steatohepatitis

Rui, L., & Lin, J. D. (2022) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-062220-105200 · Cited by 56 · see citing works

Hormone-like fibroblast growth factors and metabolic regulation

Long, Y. C., & Kharitonenkov, A. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.04.002 · Cited by 55 · see citing works

Energy-sensing Factors Coactivator Peroxisome Proliferator-activated Receptor γ Coactivator 1-α (PGC-1α) and AMP-activated Protein Kinase Control Expression of Inflammatory Mediators in Liver

Buler, M., Aatsinki, S., Skoumal, R., Komka, Z., Tóth, M., Kerkelä, R., Georgiadi, A., Kersten, S., & Hakkola, J. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.302356 · Cited by 53 · see citing works

Nutrient regulation of glucagon secretion: involvement in metabolism and diabetes

Marroquí, L., Alonso‐Magdalena, P., Merino, B., Fuentes, E., Nadal, Á., & Quesada, I. (2014) · Nutrition Research Reviews · doi:10.1017/s0954422414000031 · Cited by 55 · see citing works

Lipid sensing by PPARα: Role in controlling hepatocyte gene regulatory networks and the metabolic response to fasting

Fougerat, A., Bruse, J., Polizzi, A., Montagner, A., Guillou, H., & Wahli, W. (2024) · Progress in Lipid Research · doi:10.1016/j.plipres.2024.101303 · Cited by 54 · see citing works

Pancreatic endocrine and exocrine signaling and crosstalk in physiological and pathological status

Hu, C., Chen, Y., Yin, X., Xu, R., Yin, C., Wang, C., & Zhao, Y. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02098-3 · Cited by 59 · see citing works

A Critical Role of Fatty Acid Binding Protein 4 and 5 (FABP4/5) in the Systemic Response to Fasting

Syamsunarno, M. R. A. A., Iso, T., Hanaoka, H., Yamaguchi, A., Obokata, M., Koitabashi, N., Goto, K., Hishiki, T., Nagahata, Y., Matsui, H., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0079386 · Cited by 50 · see citing works

Structural insights into hormone recognition by the human glucose-dependent insulinotropic polypeptide receptor

Zhao, F., Zhang, C., Zhou, Q., Hang, K., Zou, X., Chen, Y., Wu, F., Rao, Q., Dai, A., Yin, W., et al. (2021) · eLife · doi:10.7554/elife.68719 · Cited by 49 · see citing works

Downregulation of the kidney glucagon receptor, essential for renal function and systemic homeostasis, contributes to chronic kidney disease

Wang, M.-Y., Zhang, Z., Zhao, S., Onodera, T., Sun, X.-N., Zhu, Q., Li, C., Li, N., Chen, S., Paredes, M., et al. (2024) · Cell Metabolism · doi:10.1016/j.cmet.2023.12.024 · Cited by 52 · see citing works

CrbpI Modulates Glucose Homeostasis and Pancreas 9-cis-Retinoic Acid Concentrations

Kane, M. A., Folias, A. E., Pingitore, A., Perri, M., Krois, C. R., Ryu, J. Y., Cione, E., & Napoli, J. L. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.05516-11 · Cited by 48 · see citing works

NIK links inflammation to hepatic steatosis by suppressing PPARα in alcoholic liver disease

Li, Y., Chen, M., Zhou, Y., Tang, C., Zhang, W., Zhong, Y., Chen, Y., Zhou, H. Y., & Sheng, L. (2020) · Theranostics · doi:10.7150/thno.40149 · Cited by 47 · see citing works

Exercise Intensity Modulation of Hepatic Lipid Metabolism

Lira, F. S., Carnevali, L. C., Zanchi, N. E., dos Santos, R. V. T., Lavoie, J.-M., & Seelaender, M. C. L. (2012) · Journal of Nutrition and Metabolism · doi:10.1155/2012/809576 · Cited by 47 · see citing works

Novel insight into glucagon receptor action: lessons from knockout and transgenic mouse models

Vuguin, P. M., & Charron, M. J. (2011) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2011.01447.x · Cited by 47 · see citing works

Glucagon as a Critical Factor in the Pathology of Diabetes

Edgerton, D. S., & Cherrington, A. D. (2011) · Diabetes · doi:10.2337/db10-1594 · Cited by 47 · see citing works

Glucagon regulates hepatic lipid metabolism via cAMP and Insig-2 signaling: implication for the pathogenesis of hypertriglyceridemia and hepatic steatosis

Wang, H., Zhao, M., Sud, N., Christian, P., Shen, J., Song, Y., Pashaj, A., Zhang, K., Carr, T. P., & Su, Q. (2016) · Scientific Reports · doi:10.1038/srep32246 · Cited by 47 · see citing works

The PDE4 inhibitor roflumilast reduces weight gain by increasing energy expenditure and leads to improved glucose metabolism

Möllmann, J., Kahles, F., Lebherz, C., Kappel, B. A., Baeck, C., Tacke, F., Werner, C., Federici, M., Marx, N., & Lehrke, M. (2016) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12839 · Cited by 48 · see citing works

Lipocalin 13 protein protects against hepatic steatosis by both inhibiting lipogenesis and stimulating fatty acid β-oxidation

Sheng, L., Cho, K. W., Zhou, Y., Shen, H., & Rui, L. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.256677 · Cited by 45 · see citing works

Cell Metabolism Article The Glucagon Receptor Is Required for the Adaptive Metabolic Response to Fasting

Longuet, C., Sinclair, E. M., Maida, A., Baggio, L. L., Maziarz, M., & Charron, M. J. (2013)

GPR109a Signaling Alters the Hepatic Response to Fasting

Foy, C. E., Hepler, C., & Renquist, B. J. (2016) · The FASEB Journal · doi:10.1096/fasebj.30.1_supplement.850.6

Glucagon-Receptor Signaling Reverses Hepatic Steatosis Independent of Leptin Receptor Expression

Nason, S. R., Kim, T., ANTIPENKO, J. P., Finan, B., DiMarchi, R. D., Hunter, C. S., & Habegger, K. M. (2019) · Endocrinology · doi:10.1210/endocr/bqz013 · Cited by 26 · see citing works

Female glucagon receptor knockout mice are prone to steatosis but resistant to weight gain when fed a MASH ‐promoting GAN diet and a high‐fat diet

Galsgaard, K. D., Elmelund, E., Hunt, J. E., Smits, M. M., Grevengoed, T. J., Christoffersen, C., Færgeman, N. J., Havelund, J. F., Albrechtsen, N. J. W., & Holst, J. J. (2025) · Physiological Reports · doi:10.14814/phy2.70235 · Cited by 2 · see citing works

Glucagon receptor antagonism impairs and glucagon receptor agonism enhances triglycerides metabolism in mice

Galsgaard, K. D., Elmelund, E., Johansen, C. D., Bomholt, A. B., Kizilkaya, H. S., Ceutz, F. R., Hunt, J. E., Kissow, H., Winther‐Sørensen, M., Sørensen, C. M., et al. (2022) · Molecular Metabolism · doi:10.1016/j.molmet.2022.101639 · Cited by 19 · see citing works